This retrospective analysis evaluated whether serum cardiac troponin T (cTnT) may serve as a biomarker of treatment response in patients with SOD1-associated amyotrophic lateral sclerosis (ALS) treated with tofersen.

Read More> https://pocncoe.com/rare-disease/home/article/ctnt-may-help-track-tofersen-response-in-sod1-als/?highlight=null